GT201100241A - Proceso para preparar compuestos antivirales - Google Patents
Proceso para preparar compuestos antiviralesInfo
- Publication number
- GT201100241A GT201100241A GT201100241A GT201100241A GT201100241A GT 201100241 A GT201100241 A GT 201100241A GT 201100241 A GT201100241 A GT 201100241A GT 201100241 A GT201100241 A GT 201100241A GT 201100241 A GT201100241 A GT 201100241A
- Authority
- GT
- Guatemala
- Prior art keywords
- antiviral compounds
- salts
- compound
- prepare
- prepare antiviral
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
(A) PROCESOS PARA PREPARAR UN COMPUESTO Y SALES DEL MISMO QUE, ENTRE OTROS, SON DE UTILIDAD PARA INHIBIR AL VIRUS DE LA HEPATITIS C (HCV); (B) INTERMEDIARIOS DE UTILIDAD PARA LA PREPARACIÓN DEL COMPUESTO Y LAS SALES; (C) COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN AL COMPUESTO O LAS SALES; Y (D) MÉTODOS PARA USAR DICHAS COMPOSICIONES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16270509P | 2009-03-24 | 2009-03-24 | |
US31671310P | 2010-03-23 | 2010-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT201100241A true GT201100241A (es) | 2015-08-19 |
Family
ID=42136100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT201100241A GT201100241A (es) | 2009-03-24 | 2011-09-20 | Proceso para preparar compuestos antivirales |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP2411372B1 (es) |
JP (1) | JP5744003B2 (es) |
KR (1) | KR101665955B1 (es) |
CN (1) | CN102361858B (es) |
AU (1) | AU2010229975B2 (es) |
BR (1) | BRPI1009854A2 (es) |
CA (1) | CA2753825C (es) |
CL (1) | CL2011002278A1 (es) |
CO (1) | CO6450678A2 (es) |
CR (1) | CR20110524A (es) |
DO (1) | DOP2011000297A (es) |
EC (1) | ECSP11011415A (es) |
ES (1) | ES2488821T3 (es) |
GT (1) | GT201100241A (es) |
HK (1) | HK1166798A1 (es) |
IL (1) | IL214858A (es) |
MX (1) | MX2011010049A (es) |
MY (1) | MY169288A (es) |
NZ (1) | NZ594923A (es) |
PE (1) | PE20120519A1 (es) |
RU (1) | RU2524573C2 (es) |
SG (1) | SG174211A1 (es) |
WO (1) | WO2010111348A1 (es) |
ZA (1) | ZA201106511B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
WO2012009699A2 (en) | 2010-07-16 | 2012-01-19 | Abbott Laboratories | Process for preparing antiviral compounds |
US8841487B2 (en) | 2010-07-16 | 2014-09-23 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
WO2012129099A1 (en) * | 2011-03-18 | 2012-09-27 | Abbott Laboratories | Formulations of phenyl uracil compounds |
US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021624A1 (fr) * | 1999-09-20 | 2001-03-29 | Fuji Photo Film Co., Ltd. | Composes destines au marquage par fluorescence |
EP1218401B1 (de) * | 1999-09-22 | 2004-06-16 | Aventis Pharma Deutschland GmbH | 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung |
DE10051981A1 (de) * | 2000-10-20 | 2002-05-02 | Bayer Ag | Substituierte Phenyluracile |
AU2007266915A1 (en) * | 2006-05-30 | 2007-12-06 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis C |
US8178548B2 (en) * | 2007-09-17 | 2012-05-15 | Abbott Laboratories | Anti-infective agents and uses thereof |
CN102746239B (zh) * | 2007-09-17 | 2016-02-10 | 艾伯维巴哈马有限公司 | 治疗丙型肝炎的尿嘧啶或胸腺嘧啶衍生物 |
EP2307372B1 (en) * | 2008-07-23 | 2012-04-25 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
-
2010
- 2010-03-24 JP JP2012502196A patent/JP5744003B2/ja active Active
- 2010-03-24 SG SG2011063179A patent/SG174211A1/en unknown
- 2010-03-24 MX MX2011010049A patent/MX2011010049A/es active IP Right Grant
- 2010-03-24 EP EP10711968.7A patent/EP2411372B1/en active Active
- 2010-03-24 PE PE2011001686A patent/PE20120519A1/es active IP Right Grant
- 2010-03-24 KR KR1020117024825A patent/KR101665955B1/ko active IP Right Grant
- 2010-03-24 CN CN201080013374.7A patent/CN102361858B/zh active Active
- 2010-03-24 ES ES10711968.7T patent/ES2488821T3/es active Active
- 2010-03-24 MY MYPI2011004471A patent/MY169288A/en unknown
- 2010-03-24 CA CA2753825A patent/CA2753825C/en active Active
- 2010-03-24 NZ NZ594923A patent/NZ594923A/xx unknown
- 2010-03-24 RU RU2011142757/04A patent/RU2524573C2/ru active
- 2010-03-24 BR BRPI1009854-2A patent/BRPI1009854A2/pt not_active Application Discontinuation
- 2010-03-24 AU AU2010229975A patent/AU2010229975B2/en active Active
- 2010-03-24 WO PCT/US2010/028433 patent/WO2010111348A1/en active Application Filing
-
2011
- 2011-08-24 EC EC2011011415A patent/ECSP11011415A/es unknown
- 2011-08-28 IL IL214858A patent/IL214858A/en active IP Right Grant
- 2011-09-06 ZA ZA2011/06511A patent/ZA201106511B/en unknown
- 2011-09-14 CL CL2011002278A patent/CL2011002278A1/es unknown
- 2011-09-20 GT GT201100241A patent/GT201100241A/es unknown
- 2011-09-21 CO CO11123197A patent/CO6450678A2/es active IP Right Grant
- 2011-09-23 DO DO2011000297A patent/DOP2011000297A/es unknown
- 2011-10-04 CR CR20110524A patent/CR20110524A/es unknown
-
2012
- 2012-08-01 HK HK12107568.3A patent/HK1166798A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI1009854A2 (pt) | 2015-08-25 |
PE20120519A1 (es) | 2012-06-03 |
KR20110137372A (ko) | 2011-12-22 |
NZ594923A (en) | 2013-11-29 |
CN102361858B (zh) | 2014-07-23 |
ECSP11011415A (es) | 2011-11-30 |
CR20110524A (es) | 2012-01-19 |
MX2011010049A (es) | 2011-10-11 |
MY169288A (en) | 2019-03-21 |
CN102361858A (zh) | 2012-02-22 |
CO6450678A2 (es) | 2012-05-31 |
EP2411372B1 (en) | 2014-07-23 |
JP5744003B2 (ja) | 2015-07-01 |
SG174211A1 (en) | 2011-10-28 |
ZA201106511B (en) | 2012-05-30 |
RU2011142757A (ru) | 2013-04-27 |
WO2010111348A1 (en) | 2010-09-30 |
EP2411372A1 (en) | 2012-02-01 |
DOP2011000297A (es) | 2011-10-15 |
CL2011002278A1 (es) | 2012-03-09 |
IL214858A0 (en) | 2011-11-30 |
KR101665955B1 (ko) | 2016-10-13 |
AU2010229975A1 (en) | 2011-09-29 |
IL214858A (en) | 2015-05-31 |
CA2753825A1 (en) | 2010-09-30 |
JP2012521990A (ja) | 2012-09-20 |
RU2524573C2 (ru) | 2014-07-27 |
CA2753825C (en) | 2017-10-17 |
ES2488821T3 (es) | 2014-08-29 |
AU2010229975B2 (en) | 2015-05-21 |
HK1166798A1 (en) | 2012-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012438A (es) | Proceso para preparar compuestos antivirales | |
CL2019000271A1 (es) | Inhibidores de polimerasa hcv. (divisional solicitud 201600493) | |
CO6761348A2 (es) | Compuestos antivirales | |
CO6430431A2 (es) | Inhibidores del virus de la hepatitis c | |
CO6361922A2 (es) | Inhibidores del virus de la hepatitis c | |
PE20230684A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro como inhibidores de la arn polimerasa | |
UY33897A (es) | Inhibidores del virus de la hepatitis c | |
CU20130157A7 (es) | 4 - aril- n- fenil- 1,3,5- triazin- 2- aminas que contienen un grupo sulfoximina | |
CL2011002830A1 (es) | Compuestos derivados de haloalquil heteroaril benzamidas; composicion farmaceutica uso de la composicion en el tratamiento de una infeccion viral, tal como el virus de la hepatitis b y c. | |
ECSP13010937A (es) | Compuestos antivirales | |
CL2014000612A1 (es) | Compuestos derivados de prolinas macrociclicas, inhibidores de las proteasas de serina del virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; y su uso para tratar una infeccion viral tal como la infeccion por el virus de la hepatitis c (vhc). | |
CR10136A (es) | Nucleósidos antivirales | |
ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
ECSP14013189A (es) | Inhibidores de la replicación de los virus de la gripe | |
UY34066A (es) | Inhibidores del virus de la hepatitis c | |
CR20110506A (es) | Inhibidores de la replicación del virus de la hepatitis c | |
CL2010001407A1 (es) | Compuestos derivados de purina y pirimidina sustituidos; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar enfermedades virales tales como hepatitis c, dengue, fiebre amarilla, polio, hepatitis a, entre otras. | |
BR112013002729A2 (pt) | inibidores de vírus de hepatite c | |
GT201100241A (es) | Proceso para preparar compuestos antivirales | |
BR112014013972A8 (pt) | inibidores de hcv nssa | |
AR086987A1 (es) | 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia | |
BR112014015582A2 (pt) | compostos antivirais | |
MX360161B (es) | Proceso para preparar compuestos antiviricos. | |
ECSP14012622A (es) | Compuestos antivirales | |
CR20140021A (es) | Compuestos antivirales |